

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of guanylate cyclase activity (GO:0031282) | 6.31815252 |
| 2 | antibacterial humoral response (GO:0019731) | 6.17659956 |
| 3 | antimicrobial humoral response (GO:0019730) | 6.03298504 |
| 4 | positive regulation of pseudopodium assembly (GO:0031274) | 5.88609447 |
| 5 | positive regulation of respiratory burst (GO:0060267) | 5.74408896 |
| 6 | angiotensin maturation (GO:0002003) | 5.43760055 |
| 7 | regulation of cellular extravasation (GO:0002691) | 5.38732791 |
| 8 | regulation of pseudopodium assembly (GO:0031272) | 5.28224223 |
| 9 | fructose metabolic process (GO:0006000) | 5.17258693 |
| 10 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.03405264 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.01780502 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.90983327 |
| 13 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.88356432 |
| 14 | NADH metabolic process (GO:0006734) | 4.82477310 |
| 15 | eosinophil chemotaxis (GO:0048245) | 4.63295123 |
| 16 | disruption of cells of other organism (GO:0044364) | 4.35030351 |
| 17 | killing of cells of other organism (GO:0031640) | 4.35030351 |
| 18 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.27724657 |
| 19 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.20858679 |
| 20 | glomerular filtration (GO:0003094) | 4.17244969 |
| 21 | eosinophil migration (GO:0072677) | 4.13239102 |
| 22 | defense response to fungus (GO:0050832) | 4.08002443 |
| 23 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.04427201 |
| 24 | GDP-mannose metabolic process (GO:0019673) | 4.01958206 |
| 25 | regulation of respiratory burst (GO:0060263) | 4.01025736 |
| 26 | regulation of cGMP biosynthetic process (GO:0030826) | 3.85567504 |
| 27 | renal filtration (GO:0097205) | 3.73461805 |
| 28 | diacylglycerol metabolic process (GO:0046339) | 3.70453605 |
| 29 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.61598861 |
| 30 | complement activation, classical pathway (GO:0006958) | 3.53524122 |
| 31 | detection of bacterium (GO:0016045) | 3.46512861 |
| 32 | detection of other organism (GO:0098543) | 3.46092627 |
| 33 | intestinal absorption (GO:0050892) | 3.34081338 |
| 34 | alkaloid metabolic process (GO:0009820) | 3.32302752 |
| 35 | chronic inflammatory response (GO:0002544) | 3.29345638 |
| 36 | vitamin A metabolic process (GO:0006776) | 3.25085965 |
| 37 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.24121061 |
| 38 | glycolipid catabolic process (GO:0019377) | 3.19046156 |
| 39 | lipoprotein transport (GO:0042953) | 3.18658895 |
| 40 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17775697 |
| 41 | regulation of cGMP metabolic process (GO:0030823) | 3.17271837 |
| 42 | cytidine metabolic process (GO:0046087) | 3.17211859 |
| 43 | cytidine catabolic process (GO:0006216) | 3.17211859 |
| 44 | cytidine deamination (GO:0009972) | 3.17211859 |
| 45 | negative regulation of cell killing (GO:0031342) | 3.16728452 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16728452 |
| 47 | leukotriene metabolic process (GO:0006691) | 3.14900826 |
| 48 | cyclooxygenase pathway (GO:0019371) | 3.13108242 |
| 49 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.12935581 |
| 50 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.12257525 |
| 51 | response to fungus (GO:0009620) | 3.10959167 |
| 52 | epoxygenase P450 pathway (GO:0019373) | 3.08185177 |
| 53 | negative regulation of leukocyte chemotaxis (GO:0002689) | 3.04143051 |
| 54 | negative regulation of epidermis development (GO:0045683) | 3.02945942 |
| 55 | digestion (GO:0007586) | 3.00783239 |
| 56 | L-ascorbic acid metabolic process (GO:0019852) | 2.95517936 |
| 57 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.93550746 |
| 58 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.93414303 |
| 59 | cellular response to cadmium ion (GO:0071276) | 2.93251096 |
| 60 | urea cycle (GO:0000050) | 2.92308276 |
| 61 | oligosaccharide catabolic process (GO:0009313) | 2.90618924 |
| 62 | complement activation (GO:0006956) | 2.89363961 |
| 63 | immunoglobulin mediated immune response (GO:0016064) | 2.86695429 |
| 64 | vitamin transport (GO:0051180) | 2.86454465 |
| 65 | cellular response to zinc ion (GO:0071294) | 2.86136538 |
| 66 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.85163783 |
| 67 | glycosphingolipid catabolic process (GO:0046479) | 2.82771717 |
| 68 | T-helper 1 type immune response (GO:0042088) | 2.82464042 |
| 69 | negative regulation of leukocyte migration (GO:0002686) | 2.81302310 |
| 70 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.80815049 |
| 71 | vitamin transmembrane transport (GO:0035461) | 2.80809613 |
| 72 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.80226330 |
| 73 | sulfur amino acid catabolic process (GO:0000098) | 2.79260902 |
| 74 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.79141300 |
| 75 | detection of external biotic stimulus (GO:0098581) | 2.78509630 |
| 76 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.76867213 |
| 77 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.76698343 |
| 78 | endocrine process (GO:0050886) | 2.76698343 |
| 79 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.76698343 |
| 80 | urea metabolic process (GO:0019627) | 2.74230865 |
| 81 | auditory receptor cell differentiation (GO:0042491) | 2.73171519 |
| 82 | regulation of triglyceride catabolic process (GO:0010896) | 2.69962812 |
| 83 | sulfation (GO:0051923) | 2.69430078 |
| 84 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.69282149 |
| 85 | peptide catabolic process (GO:0043171) | 2.68913226 |
| 86 | regulation of protein glycosylation (GO:0060049) | 2.66849324 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 2.66529260 |
| 88 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64084671 |
| 89 | modulation by symbiont of host immune response (GO:0052553) | 2.64084671 |
| 90 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64084671 |
| 91 | modulation by symbiont of host defense response (GO:0052031) | 2.64084671 |
| 92 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64084671 |
| 93 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64084671 |
| 94 | sphingolipid catabolic process (GO:0030149) | 2.63286601 |
| 95 | membrane lipid catabolic process (GO:0046466) | 2.62981897 |
| 96 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.59744042 |
| 97 | drug metabolic process (GO:0017144) | 2.58731850 |
| 98 | transcytosis (GO:0045056) | 2.58729928 |
| 99 | fucosylation (GO:0036065) | 2.57730572 |
| 100 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.57680299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.52658715 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.40684892 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.83041479 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.82574864 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.59394671 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.53657938 |
| 7 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.30541192 |
| 8 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29928928 |
| 9 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.23838231 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.20756566 |
| 11 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.12896452 |
| 12 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.05142989 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.87290213 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85320879 |
| 15 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.75357380 |
| 16 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72248772 |
| 17 | SA1_27219007_Chip-Seq_Bcells_Human | 1.68464060 |
| 18 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67027430 |
| 19 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.66036682 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.66016375 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.62789342 |
| 22 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.62759349 |
| 23 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.62653921 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.61284850 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.61263319 |
| 26 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.58480390 |
| 27 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55240083 |
| 28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.54208984 |
| 29 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.52349283 |
| 30 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.52240238 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45588118 |
| 32 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.45330736 |
| 33 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.45192698 |
| 34 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44720871 |
| 35 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.44466568 |
| 36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.44446884 |
| 37 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.43409528 |
| 38 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.40533085 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.37833238 |
| 40 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.37657124 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.36224352 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.35056390 |
| 43 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33878569 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33477825 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33184577 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.32232309 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.31741144 |
| 48 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31289361 |
| 49 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.30757815 |
| 50 | SPI1_23127762_ChIP-Seq_K562_Human | 1.30266373 |
| 51 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.29849028 |
| 52 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27510708 |
| 53 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.26350744 |
| 54 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.26043859 |
| 55 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.25171986 |
| 56 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.24686019 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23199508 |
| 58 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.22873759 |
| 59 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.22289970 |
| 60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.22052305 |
| 61 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20127122 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15224519 |
| 63 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.14763721 |
| 64 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.13953368 |
| 65 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.13626107 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11934538 |
| 67 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11378002 |
| 68 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.10054235 |
| 69 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09038904 |
| 70 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08916509 |
| 71 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08315142 |
| 72 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.06935842 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.05897384 |
| 74 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.05749107 |
| 75 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.05613023 |
| 76 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.04637410 |
| 77 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.04511734 |
| 78 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03348011 |
| 79 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03146075 |
| 80 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01934283 |
| 81 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00990828 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.00609351 |
| 83 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.00058290 |
| 84 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.99976807 |
| 85 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.99667392 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98721277 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.97728348 |
| 88 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.95603227 |
| 89 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95218715 |
| 90 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92078921 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.91941705 |
| 92 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91564510 |
| 93 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.91115397 |
| 94 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89802182 |
| 95 | P300_27268052_Chip-Seq_Bcells_Human | 0.88712183 |
| 96 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.88646767 |
| 97 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.87615993 |
| 98 | MAF_26560356_Chip-Seq_TH1_Human | 0.87095881 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.86995956 |
| 100 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.86703403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.31897016 |
| 2 | MP0001666_abnormal_nutrient_absorption | 3.77390376 |
| 3 | MP0010155_abnormal_intestine_physiology | 3.56337735 |
| 4 | MP0003724_increased_susceptibility_to | 3.20003429 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.18531285 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 2.96184724 |
| 7 | MP0009379_abnormal_foot_pigmentation | 2.93808164 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 2.63883562 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 2.34635318 |
| 10 | MP0003436_decreased_susceptibility_to | 2.32191703 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.23462131 |
| 12 | MP0009840_abnormal_foam_cell | 2.20331560 |
| 13 | MP0003879_abnormal_hair_cell | 2.10892105 |
| 14 | MP0005365_abnormal_bile_salt | 2.04960342 |
| 15 | MP0003303_peritoneal_inflammation | 2.04634460 |
| 16 | MP0004858_abnormal_nervous_system | 2.02112916 |
| 17 | MP0006082_CNS_inflammation | 1.98742753 |
| 18 | MP0003866_abnormal_defecation | 1.98502355 |
| 19 | MP0005166_decreased_susceptibility_to | 1.96333365 |
| 20 | MP0001835_abnormal_antigen_presentation | 1.92236079 |
| 21 | MP0005387_immune_system_phenotype | 1.88803266 |
| 22 | MP0001790_abnormal_immune_system | 1.88803266 |
| 23 | MP0000490_abnormal_crypts_of | 1.88244155 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.87132878 |
| 25 | MP0005409_darkened_coat_color | 1.78561424 |
| 26 | MP0005645_abnormal_hypothalamus_physiol | 1.77569922 |
| 27 | MP0001664_abnormal_digestion | 1.75804432 |
| 28 | MP0005025_abnormal_response_to | 1.75432417 |
| 29 | MP0002876_abnormal_thyroid_physiology | 1.71156806 |
| 30 | MP0009785_altered_susceptibility_to | 1.69059982 |
| 31 | MP0008260_abnormal_autophagy | 1.66752548 |
| 32 | MP0010329_abnormal_lipoprotein_level | 1.65389247 |
| 33 | MP0002419_abnormal_innate_immunity | 1.58487779 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.55879208 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.55853574 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.55157141 |
| 37 | MP0003806_abnormal_nucleotide_metabolis | 1.44146518 |
| 38 | MP0003075_altered_response_to | 1.43976454 |
| 39 | MP0002148_abnormal_hypersensitivity_rea | 1.43788812 |
| 40 | MP0005451_abnormal_body_composition | 1.43520541 |
| 41 | MP0010352_gastrointestinal_tract_polyps | 1.41459224 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.38374181 |
| 43 | MP0001663_abnormal_digestive_system | 1.37956952 |
| 44 | MP0009764_decreased_sensitivity_to | 1.32339836 |
| 45 | MP0001873_stomach_inflammation | 1.31436856 |
| 46 | MP0009643_abnormal_urine_homeostasis | 1.29301740 |
| 47 | MP0001765_abnormal_ion_homeostasis | 1.29238186 |
| 48 | MP0000477_abnormal_intestine_morphology | 1.27521160 |
| 49 | MP0000685_abnormal_immune_system | 1.26373075 |
| 50 | MP0005000_abnormal_immune_tolerance | 1.23646488 |
| 51 | MP0003329_amyloid_beta_deposits | 1.22440860 |
| 52 | MP0005174_abnormal_tail_pigmentation | 1.20405159 |
| 53 | MP0004264_abnormal_extraembryonic_tissu | 1.20269176 |
| 54 | MP0001800_abnormal_humoral_immune | 1.16975724 |
| 55 | MP0005058_abnormal_lysosome_morphology | 1.14326011 |
| 56 | MP0001819_abnormal_immune_cell | 1.13534354 |
| 57 | MP0005535_abnormal_body_temperature | 1.12947822 |
| 58 | MP0002420_abnormal_adaptive_immunity | 1.11698122 |
| 59 | MP0004147_increased_porphyrin_level | 1.09834571 |
| 60 | MP0000538_abnormal_urinary_bladder | 1.08243559 |
| 61 | MP0001756_abnormal_urination | 1.07834031 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.07616568 |
| 63 | MP0001501_abnormal_sleep_pattern | 1.04998458 |
| 64 | MP0005381_digestive/alimentary_phenotyp | 1.04315447 |
| 65 | MP0002796_impaired_skin_barrier | 1.04190873 |
| 66 | MP0002723_abnormal_immune_serum | 1.03970431 |
| 67 | MP0002452_abnormal_antigen_presenting | 1.02930664 |
| 68 | MP0000465_gastrointestinal_hemorrhage | 1.01894196 |
| 69 | MP0005332_abnormal_amino_acid | 1.00435512 |
| 70 | MP0002136_abnormal_kidney_physiology | 0.98228409 |
| 71 | MP0003718_maternal_effect | 0.98175840 |
| 72 | MP0005671_abnormal_response_to | 0.98129357 |
| 73 | MP0002166_altered_tumor_susceptibility | 0.97952143 |
| 74 | MP0008469_abnormal_protein_level | 0.96552110 |
| 75 | MP0003252_abnormal_bile_duct | 0.93599778 |
| 76 | MP0000681_abnormal_thyroid_gland | 0.93477093 |
| 77 | MP0000604_amyloidosis | 0.92993324 |
| 78 | MP0008004_abnormal_stomach_pH | 0.91066629 |
| 79 | MP0005464_abnormal_platelet_physiology | 0.89917356 |
| 80 | MP0002998_abnormal_bone_remodeling | 0.85686618 |
| 81 | MP0002396_abnormal_hematopoietic_system | 0.83937057 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.82809516 |
| 83 | MP0001764_abnormal_homeostasis | 0.80944714 |
| 84 | MP0005448_abnormal_energy_balance | 0.80741234 |
| 85 | MP0005319_abnormal_enzyme/_coenzyme | 0.80432682 |
| 86 | MP0005165_increased_susceptibility_to | 0.79930684 |
| 87 | MP0003045_fibrosis | 0.79746789 |
| 88 | MP0009278_abnormal_bone_marrow | 0.78885007 |
| 89 | MP0009780_abnormal_chondrocyte_physiolo | 0.77718301 |
| 90 | MP0000462_abnormal_digestive_system | 0.77141752 |
| 91 | MP0005310_abnormal_salivary_gland | 0.76746080 |
| 92 | MP0002971_abnormal_brown_adipose | 0.76572340 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.76242567 |
| 94 | MP0003638_abnormal_response/metabolism_ | 0.73004755 |
| 95 | MP0004947_skin_inflammation | 0.72534565 |
| 96 | MP0005636_abnormal_mineral_homeostasis | 0.72304127 |
| 97 | MP0004484_altered_response_of | 0.70180910 |
| 98 | MP0000716_abnormal_immune_system | 0.68985695 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.68566621 |
| 100 | MP0004270_analgesia | 0.67851917 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Malnutrition (HP:0004395) | 6.77076912 |
| 2 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.57071045 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 5.04449215 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.17378607 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 3.80428679 |
| 6 | Recurrent abscess formation (HP:0002722) | 3.76327785 |
| 7 | Abnormality of proline metabolism (HP:0010907) | 3.69707552 |
| 8 | Hydroxyprolinuria (HP:0003080) | 3.69707552 |
| 9 | Myositis (HP:0100614) | 3.68092093 |
| 10 | Chronic otitis media (HP:0000389) | 3.41346504 |
| 11 | Proximal tubulopathy (HP:0000114) | 3.32866019 |
| 12 | Orchitis (HP:0100796) | 3.30755670 |
| 13 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.27531309 |
| 14 | Nausea (HP:0002018) | 3.26868452 |
| 15 | Abnormality of macrophages (HP:0004311) | 3.09106132 |
| 16 | Glomerulonephritis (HP:0000099) | 3.08026826 |
| 17 | Confusion (HP:0001289) | 2.98961821 |
| 18 | Chronic diarrhea (HP:0002028) | 2.89288082 |
| 19 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.79550783 |
| 20 | Abnormality of complement system (HP:0005339) | 2.76476081 |
| 21 | Abnormality of vitamin B metabolism (HP:0004340) | 2.74108981 |
| 22 | Pustule (HP:0200039) | 2.73910678 |
| 23 | Stridor (HP:0010307) | 2.67675345 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 2.65562910 |
| 25 | Congenital sensorineural hearing impairment (HP:0008527) | 2.64907569 |
| 26 | Muscle fibrillation (HP:0010546) | 2.62659637 |
| 27 | Meningitis (HP:0001287) | 2.60290754 |
| 28 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.58800952 |
| 29 | Absent/shortened dynein arms (HP:0200106) | 2.58800952 |
| 30 | Glycosuria (HP:0003076) | 2.57814969 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 2.57814969 |
| 32 | Amyloidosis (HP:0011034) | 2.56678203 |
| 33 | Chronic obstructive pulmonary disease (HP:0006510) | 2.55044542 |
| 34 | Obstructive lung disease (HP:0006536) | 2.55044542 |
| 35 | Ankle clonus (HP:0011448) | 2.54662507 |
| 36 | Nephritis (HP:0000123) | 2.52237100 |
| 37 | Posterior subcapsular cataract (HP:0007787) | 2.51750587 |
| 38 | Retrobulbar optic neuritis (HP:0100654) | 2.50381270 |
| 39 | Optic neuritis (HP:0100653) | 2.50381270 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 2.47740520 |
| 41 | Alkalosis (HP:0001948) | 2.46013807 |
| 42 | Gingivitis (HP:0000230) | 2.45787250 |
| 43 | Complement deficiency (HP:0004431) | 2.42026372 |
| 44 | Loss of speech (HP:0002371) | 2.41652220 |
| 45 | Cellulitis (HP:0100658) | 2.41530556 |
| 46 | Recurrent skin infections (HP:0001581) | 2.39807985 |
| 47 | Hypobetalipoproteinemia (HP:0003563) | 2.38064858 |
| 48 | Metabolic alkalosis (HP:0200114) | 2.37998099 |
| 49 | Increased CSF protein (HP:0002922) | 2.37405185 |
| 50 | Petechiae (HP:0000967) | 2.36676170 |
| 51 | Encephalitis (HP:0002383) | 2.34660386 |
| 52 | Tongue fasciculations (HP:0001308) | 2.34593342 |
| 53 | Widely patent fontanelles and sutures (HP:0004492) | 2.32696198 |
| 54 | Myopathic facies (HP:0002058) | 2.27885660 |
| 55 | Fat malabsorption (HP:0002630) | 2.26647158 |
| 56 | Decreased circulating renin level (HP:0003351) | 2.26447068 |
| 57 | Hypophosphatemia (HP:0002148) | 2.26081572 |
| 58 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.24618422 |
| 59 | Recurrent sinusitis (HP:0011108) | 2.23300429 |
| 60 | Abnormality of the nasal mucosa (HP:0000433) | 2.22921994 |
| 61 | Hemoptysis (HP:0002105) | 2.22337703 |
| 62 | Abnormality of nucleobase metabolism (HP:0010932) | 2.22040512 |
| 63 | Vasculitis (HP:0002633) | 2.20482888 |
| 64 | Nasal polyposis (HP:0100582) | 2.19618666 |
| 65 | Increased IgE level (HP:0003212) | 2.17526788 |
| 66 | Increased purine levels (HP:0004368) | 2.17397219 |
| 67 | Hyperuricemia (HP:0002149) | 2.17397219 |
| 68 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.15117493 |
| 69 | Xanthomatosis (HP:0000991) | 2.14331742 |
| 70 | Recurrent fungal infections (HP:0002841) | 2.12469323 |
| 71 | Prolonged partial thromboplastin time (HP:0003645) | 2.11955380 |
| 72 | Abnormality of vitamin metabolism (HP:0100508) | 2.08775736 |
| 73 | Mediastinal lymphadenopathy (HP:0100721) | 2.06914579 |
| 74 | Agammaglobulinemia (HP:0004432) | 2.05822689 |
| 75 | Pancreatitis (HP:0001733) | 2.05161756 |
| 76 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.04645426 |
| 77 | Skin rash (HP:0000988) | 2.04237636 |
| 78 | Keratoconjunctivitis sicca (HP:0001097) | 2.03425891 |
| 79 | Ileus (HP:0002595) | 2.03395200 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 2.02562272 |
| 81 | Dicarboxylic aciduria (HP:0003215) | 2.02138550 |
| 82 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.02138550 |
| 83 | Hyperphosphaturia (HP:0003109) | 2.01137166 |
| 84 | Hemiplegia (HP:0002301) | 2.00868570 |
| 85 | Urticaria (HP:0001025) | 2.00416572 |
| 86 | Growth hormone excess (HP:0000845) | 2.00021632 |
| 87 | Premature loss of primary teeth (HP:0006323) | 1.96613943 |
| 88 | Abnormal hair laboratory examination (HP:0003328) | 1.96471523 |
| 89 | Abnormal urine phosphate concentration (HP:0012599) | 1.92876531 |
| 90 | Vacuolated lymphocytes (HP:0001922) | 1.92766530 |
| 91 | Pulmonary infiltrates (HP:0002113) | 1.92342325 |
| 92 | Peritonitis (HP:0002586) | 1.89610784 |
| 93 | Increased cerebral lipofuscin (HP:0011813) | 1.89263776 |
| 94 | Steatorrhea (HP:0002570) | 1.88325182 |
| 95 | Polygenic inheritance (HP:0010982) | 1.87443055 |
| 96 | Thin bony cortex (HP:0002753) | 1.86979752 |
| 97 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.86623063 |
| 98 | Paresthesia (HP:0003401) | 1.85380521 |
| 99 | Abnormal albumin level (HP:0012116) | 1.84584154 |
| 100 | Hypoalbuminemia (HP:0003073) | 1.84584154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ACVR1B | 4.80356113 |
| 2 | ERN1 | 4.79432121 |
| 3 | RIPK4 | 2.96886712 |
| 4 | STK24 | 2.45458705 |
| 5 | TYK2 | 2.31161083 |
| 6 | PRKG2 | 2.26746429 |
| 7 | GRK6 | 2.18190629 |
| 8 | PRKD3 | 2.16279099 |
| 9 | EPHB1 | 2.11593765 |
| 10 | PTK6 | 2.03669189 |
| 11 | MAP4K1 | 1.99808616 |
| 12 | MAP3K11 | 1.79588972 |
| 13 | EPHA4 | 1.76742229 |
| 14 | IRAK4 | 1.75534025 |
| 15 | MAP3K12 | 1.71644319 |
| 16 | BLK | 1.71154185 |
| 17 | TESK2 | 1.68800956 |
| 18 | DAPK2 | 1.63169826 |
| 19 | KIT | 1.59228478 |
| 20 | TNK2 | 1.59186045 |
| 21 | ZAP70 | 1.55648506 |
| 22 | EPHA2 | 1.49854592 |
| 23 | MAP2K2 | 1.49074533 |
| 24 | FGFR4 | 1.48212791 |
| 25 | RIPK1 | 1.45684411 |
| 26 | TBK1 | 1.43264738 |
| 27 | MAP3K1 | 1.41783781 |
| 28 | EPHA3 | 1.32066906 |
| 29 | BTK | 1.24289930 |
| 30 | MYLK | 1.23837713 |
| 31 | TAOK1 | 1.21677277 |
| 32 | STK16 | 1.21644408 |
| 33 | MST1R | 1.19350456 |
| 34 | PRKD2 | 1.15656818 |
| 35 | GRK1 | 1.15439014 |
| 36 | CSK | 1.14889304 |
| 37 | SIK3 | 1.12495249 |
| 38 | SYK | 1.12352476 |
| 39 | JAK2 | 1.09193344 |
| 40 | PDPK1 | 1.08279425 |
| 41 | MAP2K3 | 0.97630099 |
| 42 | KSR2 | 0.96482989 |
| 43 | EPHB2 | 0.96229967 |
| 44 | PRPF4B | 0.93712548 |
| 45 | MAP2K6 | 0.93290434 |
| 46 | CDK19 | 0.93002066 |
| 47 | JAK3 | 0.92547487 |
| 48 | IRAK1 | 0.91884002 |
| 49 | IKBKE | 0.91692300 |
| 50 | ITK | 0.90150331 |
| 51 | FES | 0.88876830 |
| 52 | TEC | 0.87727207 |
| 53 | ILK | 0.87691740 |
| 54 | MAP3K2 | 0.87182574 |
| 55 | PRKCZ | 0.85353406 |
| 56 | OXSR1 | 0.84897390 |
| 57 | LYN | 0.83824381 |
| 58 | MAP3K3 | 0.78489733 |
| 59 | ABL2 | 0.74956403 |
| 60 | MATK | 0.74876060 |
| 61 | HCK | 0.74422426 |
| 62 | JAK1 | 0.72887904 |
| 63 | SMG1 | 0.72568327 |
| 64 | MAPKAPK3 | 0.72151903 |
| 65 | BMX | 0.71281121 |
| 66 | DDR2 | 0.68809099 |
| 67 | TRIB3 | 0.67524204 |
| 68 | TESK1 | 0.65371200 |
| 69 | FGFR3 | 0.65095344 |
| 70 | TXK | 0.62692737 |
| 71 | PDK1 | 0.61623994 |
| 72 | PRKCQ | 0.61451808 |
| 73 | SIK1 | 0.61188499 |
| 74 | ERBB2 | 0.58660208 |
| 75 | LCK | 0.57968992 |
| 76 | PAK6 | 0.57820586 |
| 77 | ADRBK2 | 0.56530735 |
| 78 | DAPK1 | 0.55255907 |
| 79 | FER | 0.54940045 |
| 80 | LRRK2 | 0.54454942 |
| 81 | PRKCA | 0.52508032 |
| 82 | FGR | 0.50529786 |
| 83 | SRC | 0.49543535 |
| 84 | BMPR2 | 0.49038746 |
| 85 | RPS6KA2 | 0.46683097 |
| 86 | CSF1R | 0.46421849 |
| 87 | CDC42BPA | 0.46392322 |
| 88 | ADRBK1 | 0.44898611 |
| 89 | DYRK1B | 0.44726435 |
| 90 | HIPK2 | 0.43447820 |
| 91 | PRKCD | 0.42912391 |
| 92 | PAK4 | 0.42876088 |
| 93 | PTK2B | 0.42659046 |
| 94 | RPS6KL1 | 0.42591927 |
| 95 | RPS6KC1 | 0.42591927 |
| 96 | PRKACG | 0.42112698 |
| 97 | TAOK2 | 0.41540359 |
| 98 | TNIK | 0.38885363 |
| 99 | RPS6KA6 | 0.38345479 |
| 100 | FYN | 0.38333375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 5.13155965 |
| 2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.77907375 |
| 3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.56335435 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.14056196 |
| 5 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.73574526 |
| 6 | Asthma_Homo sapiens_hsa05310 | 2.53690486 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32213391 |
| 8 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.23974993 |
| 9 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.13079731 |
| 10 | Mineral absorption_Homo sapiens_hsa04978 | 1.99787414 |
| 11 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.88137216 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.84414147 |
| 13 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.82866967 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.78496768 |
| 15 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.71989301 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.71001040 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.66167198 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.64659473 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.57637671 |
| 20 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55540001 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.49149887 |
| 22 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.47528074 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.47525350 |
| 24 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.46728350 |
| 25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36666983 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30457264 |
| 27 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.26015434 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.25825954 |
| 29 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.25111411 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.23999050 |
| 31 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.20770424 |
| 32 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.18615747 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.10373896 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.09800312 |
| 35 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.07310978 |
| 36 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02758912 |
| 37 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94025767 |
| 38 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.89495838 |
| 39 | Tuberculosis_Homo sapiens_hsa05152 | 0.87899671 |
| 40 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.84828339 |
| 41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.83018605 |
| 42 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82806643 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 0.81759977 |
| 44 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.80722561 |
| 45 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.79805320 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.78925814 |
| 47 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.78448666 |
| 48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.76625646 |
| 49 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76384086 |
| 50 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.74879609 |
| 51 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74738590 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 0.73692196 |
| 53 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72821630 |
| 54 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72623858 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68457314 |
| 56 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.66731003 |
| 57 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.64216951 |
| 58 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.62571043 |
| 59 | Phagosome_Homo sapiens_hsa04145 | 0.61266167 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.60045756 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58882054 |
| 62 | Hepatitis C_Homo sapiens_hsa05160 | 0.57494809 |
| 63 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.55955807 |
| 64 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.53056010 |
| 65 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52319052 |
| 66 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.51650103 |
| 67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50159851 |
| 68 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.50098535 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47585262 |
| 70 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.46983109 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.45789429 |
| 72 | Influenza A_Homo sapiens_hsa05164 | 0.45754438 |
| 73 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45752845 |
| 74 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.44513266 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43420620 |
| 76 | Prion diseases_Homo sapiens_hsa05020 | 0.42191122 |
| 77 | Insulin secretion_Homo sapiens_hsa04911 | 0.40520797 |
| 78 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40361975 |
| 79 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37823116 |
| 80 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.36913536 |
| 81 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35570826 |
| 82 | Lysosome_Homo sapiens_hsa04142 | 0.33279988 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32176828 |
| 84 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31767212 |
| 85 | Renin secretion_Homo sapiens_hsa04924 | 0.31329952 |
| 86 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30450228 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.29983569 |
| 88 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29628900 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.28697099 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.26580136 |
| 91 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.25876621 |
| 92 | Amoebiasis_Homo sapiens_hsa05146 | 0.25847773 |
| 93 | Salmonella infection_Homo sapiens_hsa05132 | 0.25805358 |
| 94 | Peroxisome_Homo sapiens_hsa04146 | 0.25384412 |
| 95 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.24696868 |
| 96 | Salivary secretion_Homo sapiens_hsa04970 | 0.24519062 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.23616294 |
| 98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.23073568 |
| 99 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.22431674 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.22253133 |

